Effect of a novel vasoconstrictor endothelin-1 (1-31) on human umbilical artery

Biochem Biophys Res Commun. 2000 Apr 13;270(2):622-4. doi: 10.1006/bbrc.2000.2476.

Abstract

To clarify the action of a novel endothelin-1 with 31 amino acids, ET-1 (1-31), on fetal circulation, its vasoconstrictive activity on human umbilical and uterine arteries was investigated in comparison with that of a conventional ET-1 (1-21). UFER micro-easy magnus was used for determination of vasoconstriction. The contraction of umbilical artery by KCl was significantly weaker than that of the uterine artery. In ETs, constriction by KCl was set as control, and the rate of constriction of uterine and umbilical arteries was used for comparison. The constriction of human uterine artery induced by ET-1 (1-31) was also significantly weaker than that by ET-1 (1-21). On the contrary, ET-1 (1-31) was a potent constrictor on the umbilical artery equally to ET-1 (1-21). The present study is the first to demonstrate that ET-1 (1-31) has a contractile activity on human vessels. Furthermore, the regulatory mechanism on constriction of umbilical artery is different from that observed in a systemic vessel, indicating a particularly important role of ET-1 (1-31) in fetal circulation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Endothelin-1 / analogs & derivatives
  • Endothelins / pharmacology*
  • Female
  • Humans
  • Middle Aged
  • Peptide Fragments / pharmacology*
  • Pregnancy
  • Umbilical Arteries / drug effects*
  • Umbilical Arteries / physiology
  • Vasoconstrictor Agents / pharmacology*

Substances

  • Endothelin-1
  • Endothelins
  • Peptide Fragments
  • Vasoconstrictor Agents
  • endothelin-1 (1-31)